Merck & Co., Inc. — Director's Dealing 2020

Jan 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-01-13

Reporting Person: Gerberding Julie L. (EVP Strat Comm, GI Pub Policy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-13	Common Stock	M	49536	—	Acquired	106099.366	Direct
2020-01-13	Common Stock	M	33012	—	Acquired	139111.366	Direct
2020-01-13	Common Stock	S	102073	$89.3367	Disposed	37038.366	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-13	Stock Option (Right to Buy)	$59.86	M	49536	Disposed	2025-04-30	Common Stock (49536)	Direct
2020-01-13	Stock Option (Right to Buy)	$58.22	M	33012	Disposed	2024-05-01	Common Stock (33012)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.04 to $89.61, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F3: Holdings include shares acquired in dividend reinvestment transactions.

F4: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.

F5: The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017.